DEVELOPMENT AND INNOVATION IN CARDIOVASCULAR MEDICINE - Innovation in the Biopharmaceutical Industry - page 42

Ferreira, SH, S, Moncada and JR Vane (1971). Indomethicin and aspirin abolish

prostaglandin release from the spleen. Nature New Biology , 231, 237-239.
Gruentzig, AR, A Seining and WE Seigenthaler (1979). Non-operative dilatation of coro-
nary artery stenosis in percutaneous transluminal coronary angioplasty. The New Eng-
land Journal of Medicine , 301, 61-68.
Head, A, MJ Kendall and S Maxwell (1995). Exercise metabolism during 1 hour of tread-
mill walking while taking high and low doses of propranolol, metoprolol or placebo.
Clinical Cardiology , 18, 335-340.
Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection Study of
cholesterol lowering with simvastatin in 20 536 high risk individuals: a randomized
placebo controlled trial. Lancet , 306, 7-22.
Hurst, JW (1985). History of cardiac catheterisation. In SB King III and JS Douglas (eds.),
pp. 1-9. McGraw-Hill.
ISIS-2 (Second International Study of Infarct Survival) Collaboration Group (1988). Ran-
domised trial of intravenous streptokinase, oral aspirin, both or neither among cases
of suspected acute myocardial infarction: ISIS-2. Lancet , 1, 397-402.
Italian Group for the Study of Streptokinase in Myocardial Infarction (GISSI) (1986).
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.
Lancet , 22(8478), 397-402.
Joshi, PI, JJ Dalal, MS Ruttley, DJ Sheridan and AH Henderson (1981). Nifedipine and left
ventricular function in beta-blocked patients. British Heart Journal , 45(4), 457-459.
Julian, DG (2001). The evolution of the coronary care unit. Cardiovascular Research , 51(4),
621-624.
Kang, PM, AJ Landou, RT Eberhardt and WH Frishman (1994). Angiotensin II receptor
antagonists: A new approach to blockade of the renin-angiotensin system. American
Heart Journal , 127, 1388-1401.
Kay, N, A Epstein and S Dailey (1992). Selective radiofrequency ablation of the slow
pathway for the treatment of atrioventricular nodal re-entrant tachycardia. Circulation ,
85, 1675-1688.
Keidel, WD (1950). New method of recording changes in volume of the human heart.
Zeitschrift fur Kreislaufforschung , 39(9-10), 257-271.
Lands, AM, A Arnold, JA McAuliff, FP Luduena and TG Brown Jr (1967). Differentiation
of receptor systems activated by sympathomimetic amines. Nature , 214, 597-598.
Mark, AL (1995). Sympathetic dysregulation in heart failure; mechanisms and therapy.
Clinical Cardiology , 18(Suppl. I), I-3-I-8.
Mock, MB, I Ringqvist, LD Fisher, KB Davis, BR Chaitman, NT Kouchoukos, GC Kaiser,
E Alderman, TJ Ryan, RO Russell, Jr, S Mullin, D Fray and T Killip 3rd (1982).
Survival of medically treated patients in the coronary artery Surgery Study (CASS)
Registry. Circulation , 66, 562-568.
Morice, MC, PW Serruys, JE Sausa, J Fajadet, E Ban Hayashi, M Perin, A Colombo,
G Schuler, P Barragan, G Guagliumi, F Molnar and R Falotico (2002). RAVEL
Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-
Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery